Functional Bioassays for Immune Monitoring of High-Risk Neuroblastoma Patients Treated with ch14.18/CHO Anti-GD(2) Antibody

Effective treatment of high-risk neuroblastoma (NB) remains a major challenge in pediatric oncology. Human/mouse chimeric monoclonal anti-GD(2) antibody (mAb) ch14.18 is emerging as a treatment option to improve outcome. After establishing a production process in Chinese hamster ovary (CHO) cells, c...

Descripción completa

Detalles Bibliográficos
Autores principales: Siebert, Nikolai, Seidel, Diana, Eger, Christin, Jüttner, Madlen, Lode, Holger N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4167242/
https://www.ncbi.nlm.nih.gov/pubmed/25226154
http://dx.doi.org/10.1371/journal.pone.0107692

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4167242/
https://www.ncbi.nlm.nih.gov/pubmed/25226154
http://dx.doi.org/10.1371/journal.pone.0107692

Ejemplares similares